Heroin Addiction
10
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
30%
3 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
PET/MRI Study on the Neurological Mechanism of rTMS Treatment for Heroin Addiction
Buprenorphine for Prisoners
Observational Study to Assess the Adequacy of Methadone Dosage, in Heroin Addicted Patients in a MMT.
Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification
Malmö Treatment Referral and Intervention Study
Methadone Maintenance for Prisoners
Observational Study to Assess the Efficacy and Tolerability of Eptadone®, in Heroin Addicted Patients in a MMT
Decision Making Deficit and DNA Methylation in Opioid Receptor Genes Among Community Heroin Addicts
Methadone Maintenance Treatment Outcome Study in Taiwan
Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches